• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阴道镜检查和人乳头瘤病毒DNA检测作为巴氏涂片异常患者的分流标准。

Cervicography and HPV DNA testing as triage criteria for patients with abnormal pap smear.

作者信息

Costa S, Sideri M, Bucchi L, Schettino F, Maini I, Spinaci L, Bovicelli L, Terzano P

机构信息

Department II of Obstetrics and Gynecology, St. Orsola Hospital, Bologna, Italy.

出版信息

Gynecol Oncol. 1998 Dec;71(3):404-9. doi: 10.1006/gyno.1998.5183.

DOI:10.1006/gyno.1998.5183
PMID:9887239
Abstract

Cervicography and HPV DNA testing have been proposed as intermediate triage techniques for the management of patients with Pap smear showing minor-grade atypia. The aims of the present study of 221 patients with positive Pap smear (ages 16-65) were (1) to evaluate the association of cervicography and HPV DNA test with the probability of biopsy and final histology diagnosis of CIN2 or worse, (2) to identify the combinations of results on cervicography and HPV DNA test associated with the absence of such lesions, and (3) to estimate the cost of a potential triage protocol for patients with HPV-CIN1 smear. The probability of biopsy showed a univariate association with the severity of the smear result and the cervicography classification but not the HPV DNA test. In the multivariate analysis, only the cervicography result was a significant predictor of biopsy. The final histology diagnosis showed a univariate association with each of the three tests and a multivariate association with the degree of cytology positivity and the cervicography result. Among patients with HPV-CIN1 smears, only a negative cervicography (with any HPV DNA test result) was always associated with the absence of severe histologic lesions. This pattern accounted only for 7% of such patients. The additional costs of a potential triage protocol based on cervicography were estimated to exceed the savings resulting from the reduced colposcopy rate.

摘要

宫颈涂片检查和人乳头瘤病毒(HPV)DNA检测已被提议作为对巴氏涂片显示轻度不典型增生患者进行管理的中间分流技术。本研究纳入了221例巴氏涂片阳性患者(年龄16 - 65岁),目的如下:(1)评估宫颈涂片检查和HPV DNA检测与活检概率以及CIN2或更严重病变最终组织学诊断的相关性;(2)确定宫颈涂片检查和HPV DNA检测结果的组合与不存在此类病变的相关性;(3)估算针对HPV - CIN1涂片患者的潜在分流方案的成本。活检概率在单因素分析中与涂片结果的严重程度和宫颈涂片检查分类相关,但与HPV DNA检测无关。在多因素分析中,只有宫颈涂片检查结果是活检的显著预测因素。最终组织学诊断在单因素分析中与这三项检测中的每一项都相关,在多因素分析中与细胞学阳性程度和宫颈涂片检查结果相关。在HPV - CIN1涂片患者中,只有宫颈涂片检查结果为阴性(无论HPV DNA检测结果如何)始终与不存在严重组织学病变相关。这种模式仅占此类患者的7%。基于宫颈涂片检查的潜在分流方案的额外成本估计超过了因阴道镜检查率降低而节省的费用。

相似文献

1
Cervicography and HPV DNA testing as triage criteria for patients with abnormal pap smear.阴道镜检查和人乳头瘤病毒DNA检测作为巴氏涂片异常患者的分流标准。
Gynecol Oncol. 1998 Dec;71(3):404-9. doi: 10.1006/gyno.1998.5183.
2
Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?巴氏涂片报告中不典型鳞状细胞(ASCUS)和低度鳞状上皮内病变(LSIL)女性的分流:通过重复巴氏涂片、人乳头瘤病毒(HPV)DNA检测或阴道镜检查进行管理?
J Fam Pract. 1998 Feb;46(2):125-34.
3
Searching for an ideal cervical cancer screening model to reduce false-negative errors in a country with high prevalence of cervical cancer.在宫颈癌高发国家寻找一种理想的宫颈癌筛查模型,以减少假阴性错误。
J Obstet Gynaecol. 2020 Feb;40(2):240-246. doi: 10.1080/01443615.2019.1621813. Epub 2019 Jul 25.
4
Screening capacity and cost-effectiveness of the human papillomavirus test versus cervicography as an adjunctive test to Pap cytology to detect high-grade cervical dysplasia.人乳头瘤病毒检测与子宫颈造影术作为巴氏细胞学辅助检测手段用于检测高级别宫颈发育异常的筛查能力及成本效益
Eur J Obstet Gynecol Reprod Biol. 2019 Mar;234:112-116. doi: 10.1016/j.ejogrb.2019.01.008. Epub 2019 Jan 17.
5
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.识别患有宫颈肿瘤的女性:对巴氏涂片结果不明确者使用人乳头瘤病毒DNA检测
JAMA. 1999 May 5;281(17):1605-10. doi: 10.1001/jama.281.17.1605.
6
Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer.联合巴氏涂片检查、子宫颈造影术和人乳头瘤病毒DNA检测用于检测宫颈上皮内瘤变和癌症。
Acta Cytol. 2000 May-Jun;44(3):310-8. doi: 10.1159/000328471.
7
Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.人乳头瘤病毒(HPV)检测在巴氏涂片异常女性管理中的应用。一家阴道镜转诊诊所的经验。
Eur J Gynaecol Oncol. 2004;25(5):577-84.
8
Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.高危型人乳头瘤病毒 DNA 检测作为宫颈癌筛查计划中的主要检测方法:一项基于人群的队列研究。
BJOG. 2013 Sep;120(10):1260-7; discussion 1267-8. doi: 10.1111/1471-0528.12272. Epub 2013 Jun 21.
9
HPV DNA testing as an adjunct in the management of patients with low grade cytological lesions in Finland.
Acta Obstet Gynecol Scand. 2007;86(3):367-72. doi: 10.1080/00016340601185343.
10
Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL.在巴氏涂片报告为非典型鳞状细胞意义不明确(ASCUS)和低度鳞状上皮内病变(LSIL)的女性中,两种检测致癌性人乳头瘤病毒(HPV)方法的比较。
J Fam Pract. 1998 Feb;46(2):136-41.

引用本文的文献

1
Prediction of high-grade squamous intraepithelial lesions using the modified Reid index.应用改良 Reid 指数预测高级别鳞状上皮内病变。
Int J Clin Oncol. 2010 Feb;15(1):65-9. doi: 10.1007/s10147-009-0012-6. Epub 2010 Jan 20.